Sep 22, 09:13
Only BuyersOnly Buyers in Dr Datson Labs on BSE
Dr Datson Labs
79% of moneycontrol users recommend buying Dr Datson Labs.
What's your call on Dr Datson Labs today?
Read 99 investor views
|Company Name||Last Price||%
|Dr Reddys Labs||3212.20||-0.19||3240.00||2420.00||54,724.91|
|Mar' 14||Sep' 13||Jun' 13||Mar' 13|
|No Mutual Funds Holding the share|
RS Software (India) Recommended on Aug 12th 2014
Recommended price 430.00 | Peak from reco 829.30 92.86%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
Dr Datson Labs is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 90.47 crore.The company has reported a standalone sales of Rs 201.44 crore and a Net Profit of Rs 0.06 crore for the quarter ended Jun 2014.
The company management includes Kannan Vishwanath - Vice Chairman & Mng.Director, Shashikant Shinde - Executive & Wholetime Director, Prabhat Kumar Goyal - Non Exe.Non Ind.Director, Giridhar Gopal Pulleti - Ind. Non-Executive Director, Minhaj Khan - Ind. Non-Executive Director.
It is listed on the BSE with a BSE Code of 533412 and the NSE with an NSE Code of DRDATSONS.
Its Registered office is at API & R&D Centre: K-4/1 Additional MIDC,,Mahad Raigad District,Maharashtra - 403209.
Their Registrars are Link Intime India Pvt. Ltd.